prednisone has been researched along with nafcillin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brook, J; Green, RE; Karassik, SL; Subramanyam, L | 1 |
| Blecher, MH; Cohen, EJ; Donnenfeld, ED; Genvert, GI | 1 |
| Leyden, JJ; Rudolph, RI; Schwartz, W | 1 |
| Leclair, SJ; Scarano, FJ; Tang, Y | 1 |
1 review(s) available for prednisone and nafcillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for prednisone and nafcillin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Disseminated Nocardia brasiliensis infection.
Topics: Adult; Hodgkin Disease; Humans; Male; Nafcillin; Nitrogen Mustard Compounds; Nocardia Infections; Prednisone; Procarbazine; Skin Diseases, Infectious; Sulfadiazine; Vincristine | 1976 |
Erythema multiforme after use of topical sulfacetamide.
Topics: Child; Conjunctivitis; Drug Eruptions; Drug Hypersensitivity; Erythromycin; Humans; Male; Nafcillin; Ophthalmic Solutions; Prednisolone; Prednisone; Stevens-Johnson Syndrome; Sulfacetamide | 1985 |
Treatment of staphylococcal toxic epidermal necrolysis.
Topics: Administration, Oral; Anti-Bacterial Agents; Child, Preschool; Cortisone; Dexamethasone; Dicloxacillin; Erythromycin; Female; Glucocorticoids; Humans; Hydrocortisone; Infant; Infant, Newborn; Injections, Intravenous; Length of Stay; Male; Nafcillin; Prednisone; Staphylococcal Infections; Stevens-Johnson Syndrome; Time Factors | 1974 |
Septicemic arthritis with antibiotic resistance: a case study.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Bacteremia; beta-Lactam Resistance; Cross Infection; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Humans; Leukopenia; Male; Middle Aged; Nafcillin; Prednisone; Staphylococcal Infections; Vancomycin | 2008 |